Implementing Machine Learning to Predict Survival Outcomes in Patients with Resected Pulmonary Large Cell Neuroendocrine Carcinoma.

This study introduces a novel machine learning-based prognostic model with a supportive web-based platform, offering valuable tools for healthcare professionals. These advancements facilitate more personalized clinical decision-making for PLCNEC patients following primary tumor resection.